Geninus Inc (389030)

Currency in KRW
1,702
-1(-0.06%)
Closed·
389030 Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
389030 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,6511,713
52 wk Range
1,0802,935
Key Statistics
Bid/Ask
1,702.00 / 1,704.00
Prev. Close
1,703
Open
1,703
Day's Range
1,651-1,713
52 wk Range
1,080-2,935
Volume
163.41K
Average Volume (3m)
404.34K
1-Year Change
29.66%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
389030 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Geninus Inc Company Profile

GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea. It offers CancerSCAN, an NGS-based cancer genome diagnosis solution; LiquidSCAN, a liquid biopsy NGS test; and Celinus, a single-cell analysis solution for ultra-precise genome analysis. The company also provides HealthSCAN, a genetic test service; WithMe, a service that analyzes gut bacteria characteristics related to the risk of chronic diseases; and OncoSTATION, an automated clinical genome information analysis solution. It serves hospitals, pharmaceutical companies, and researchers. The company was incorporated in 2018 and is based in Seoul, South Korea.

Compare 389030 to Peers and Sector

Metrics to compare
389030
Peers
Sector
Relationship
P/E Ratio
−4.7x−5.0x−0.5x
PEG Ratio
0.33−0.100.00
Price/Book
2.8x2.0x2.6x
Price / LTM Sales
7.6x5.1x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock7.3%6.9%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-71.00 / --
Revenue / Forecast
2.63B / --
EPS Revisions
Last 90 days

389030 Income Statement

FAQ

What Stock Exchange Does Geninus Trade On?

Geninus is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Geninus?

The stock symbol for Geninus is "389030."

What Is the Geninus Market Cap?

As of today, Geninus market cap is 56.80B.

What Is Geninus's Earnings Per Share (TTM)?

The Geninus EPS (TTM) is -353.13.

From a Technical Analysis Perspective, Is 389030 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Geninus Stock Split?

Geninus has split 1 times.

How Many Employees Does Geninus Have?

Geninus has 74 employees.

What is the current trading status of Geninus (389030)?

As of 07 Aug 2025, Geninus (389030) is trading at a price of 1,702.00, with a previous close of 1,703.00. The stock has fluctuated within a day range of 1,651.00 to 1,713.00, while its 52-week range spans from 1,080.00 to 2,935.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.